Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double-masked, Randomized, Sham-controlled, Multiple-dose Study of the Efficacy and Safety of Intravitreal KUS121 in the Treatment of Non-Arteritic Central Retinal Artery Occlusion (CRAO)

NCT06178055 is registered in ClinicalTrials.gov with Kyoto Drug Discovery and Development Co., Ltd. as lead sponsor.

NCT NCT06178055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06178055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double-masked, Randomized, Sham-controlled, Multiple-dose Study of the Efficacy and Safety of Intravitreal KUS121 in the Treatment of Non-Arteritic Central Retinal Artery Occlusion (CRAO)
Lead sponsor
Kyoto Drug Discovery and Development Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
April 16, 2024
Completion date
November 30, 2025
Enrollment
17 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

central retinal artery occlusion